Internal Medicine, Endocrinology, Diabetes, & Metabolism · Sewell, NJ
NPI
1548455314
Since 2007
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
239 Hurffville Crosskeys Rd, Ste 370
Sewell, NJ, 08080
Phone (856) 728-3636
Groups this clinician bills Medicare through
Medicare paid, 2024
$155K
2,389 services
Medicare patients, 2024
664
Average age 73
Drug cost, 2024
$2.2M
4,283 prescriptions
Company payments, 2025
$1,577
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Charles Delgiorno was code 99214 (office e&m - established), 1,185 times for 610 patients. In total Charles Delgiorno billed 2,389 services in 15 codes, and Medicare paid $155K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-03-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,185 | 610 | $99.08 | $117K |
| 95251 Test - Miscellaneous | Office | 563 | 254 | $27.16 | $15K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 380 | 271 | $12.93 | $4,914 |
| 83036 Blood Count | Office | 52 | 48 | $9.52 | $495 |
| 99204 Office E&M - New | Office | 50 | 50 | $129.96 | $6,498 |
| 99215 Office E&M - Established | Office | 41 | 37 | $151.14 | $6,197 |
| 82962 Clinical Chemistry | Office | 21 | 20 | $3.21 | $67.41 |
| 95249 Test - Miscellaneous | Office | 14 | 14 | $54.74 | $766 |
| 95250 Test - Miscellaneous | Office | 11 | 11 | $109.44 | $1,204 |
By year: 2022 $117K for 1,370 services; 2023 $129K for 1,658 services; 2024 $155K for 2,389 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 52 | 48 | $9.52 | $495 |
| 82962 Clinical Chemistry | 21 | 20 | $3.21 | $67.41 |
Medicare prescription drug claims, 2024
In 2024, the drug Charles Delgiorno prescribed most often to Medicare patients was Levothyroxine Sodium, with 530 prescriptions and refills. In total Charles Delgiorno wrote 4,283 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 530 | 1,552 | 170 | $7,429 |
| Metformin Hcl Generic | 449 | 1,327 | 144 | $5,049 |
| Ozempic Semaglutide | 284 | 614 | 80 | $578K |
| Glipizide Generic | 206 | 615 | 80 | $3,008 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 173 | 443 | 83 | $19K |
| Metformin Hcl Er Metformin Hcl | 172 | 511 | 61 | $2,690 |
| Methimazole Generic | 157 | 450 | 45 | $1,779 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 143 | 400 | 69 | $28K |
| Mounjaro Tirzepatide | 139 | 202 | 46 | $206K |
| Trulicity Dulaglutide | 117 | 232 | 32 | $222K |
| Synthroid Levothyroxine Sodium | 113 | 324 | 33 | $9,344 |
| Glimepiride Generic | 85 | 251 | 27 | $1,368 |
| Glipizide Er Glipizide | 84 | 244 | 26 | $2,229 |
| Novolog Flexpen Insulin Aspart | 82 | 252 | 43 | $34K |
| Novolog Insulin Aspart | 71 | 153 | 24 | $34K |
Brand drugs: 1,874 claims; generic drugs: 1,998 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Charles Delgiorno $1,577 ($1,577 in general payments such as food, travel and fees) from 24 companies. The largest payer was Insulet Corporation with $222.
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation PODD | 10 | $222 |
| Lilly USA, LLC LLY | 10 | $179 |
| Abbott Laboratories ABT | 11 | $137 |
| Novo Nordisk Inc NVO | 7 | $126 |
| Amphastar Pharmaceuticals, Inc. AMPH | 6 | $105 |
| Tandem Diabetes Care, Inc. TNDM | 4 | $96.87 |
| Madrigal Pharmaceuticals MDGL | 4 | $85.38 |
| Amgen Inc. AMGN | 5 | $85.07 |
| Mannkind Corporation MNKD | 1 | $84.67 |
| Beta Bionics, Inc. BBNX | 3 | $73.57 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.